Press Room

Article / Jun 01, 2009

Substandard APIs: we must tackle the problem together

Pharmaceutical Technology Europe, June, 2009

Contrary to what some would have you believe, the use of substandard APIs in European medicines puts patient health and pharmaceutical manufacturers' reputations at risk. Most APIs destined for the EU come from Asian plants that have never been inspected by an EU official. To ensure a minimum level of quality, agencies and regulators from both sides of the Atlantic must work together to provide API compliance oversight.

Read article here

Also in the Press Room

Press Release / Mar 07, 2018

Hovione sells the iMAX business

Hovione announces that it has concluded the sale of all of the share capital of iMAX Diagnostic Imaging limited.